$0.4959
+0.02
(+3.31%)▲
Insights on American Well Corporation
Revenue is down for the last 2 quarters, 70.67M → 59.52M (in $), with an average decrease of 15.8% per quarter
Netprofit is down for the last 2 quarters, -48.58M → -72.10M (in $), with an average decrease of 48.4% per quarter
In the last 1 year, Healthequity Inc has given 35.6% return, outperforming this stock by 114.1%
In the last 3 years, Healthequity Inc has given 1.5% return, outperforming this stock by 97.4%
6.0%
Downside
Day's Volatility :7.84%
Upside
1.96%
9.7%
Downside
52 Weeks Volatility :83.52%
Upside
81.75%
Period | American Well Corporation | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -55.56% | -0.6% | 0.0% |
6 Months | -59.32% | 12.1% | 0.0% |
1 Year | -78.48% | 11.3% | 0.0% |
3 Years | -95.84% | 17.6% | -20.1% |
Market Capitalization | 150.7M |
Book Value | $1.38 |
Earnings Per Share (EPS) | -1.21 |
Wall Street Target Price | 1.94 |
Profit Margin | -137.32% |
Operating Margin TTM | -126.06% |
Return On Assets TTM | -23.17% |
Return On Equity TTM | -62.25% |
Revenue TTM | 254.6M |
Revenue Per Share TTM | 0.89 |
Quarterly Revenue Growth YOY | -7.000000000000001% |
Gross Profit TTM | 116.8M |
EBITDA | -233.0M |
Diluted Eps TTM | -1.21 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.82 |
EPS Estimate Next Year | -0.49 |
EPS Estimate Current Quarter | -0.19 |
EPS Estimate Next Quarter | -0.18 |
What analysts predicted
Upside of 291.21%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 114.0M | - |
Net Income | -52.7M | - |
Net Profit Margin | -46.22% | - |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 148.9M | ↑ 30.63% |
Net Income | -88.4M | ↑ 67.76% |
Net Profit Margin | -59.36% | ↓ 13.14% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 245.3M | ↑ 64.77% |
Net Income | -226.4M | ↑ 156.25% |
Net Profit Margin | -92.32% | ↓ 32.96% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 252.8M | ↑ 3.07% |
Net Income | -173.7M | ↓ 23.31% |
Net Profit Margin | -68.69% | ↑ 23.63% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 277.2M | ↑ 9.65% |
Net Income | -269.8M | ↑ 55.37% |
Net Profit Margin | -97.33% | ↓ 28.64% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 259.0M | ↓ 6.55% |
Net Income | -675.2M | ↑ 150.25% |
Net Profit Margin | -260.63% | ↓ 163.3% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 79.2M | ↑ 14.48% |
Net Income | -60.7M | ↓ 13.31% |
Net Profit Margin | -76.57% | ↑ 24.55% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 64.0M | ↓ 19.22% |
Net Income | -397.9M | ↑ 555.78% |
Net Profit Margin | -621.64% | ↓ 545.07% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 62.4M | ↓ 2.43% |
Net Income | -92.5M | ↓ 76.76% |
Net Profit Margin | -148.09% | ↑ 473.55% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 61.9M | ↓ 0.84% |
Net Income | -136.4M | ↑ 47.51% |
Net Profit Margin | -220.3% | ↓ 72.21% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 70.7M | ↑ 14.14% |
Net Income | -48.6M | ↓ 64.38% |
Net Profit Margin | -68.75% | ↑ 151.55% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 59.5M | ↓ 15.78% |
Net Income | -72.1M | ↑ 48.4% |
Net Profit Margin | -121.14% | ↓ 52.39% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 489.3M | - |
Total Liabilities | 693.7M | - |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 499.9M | ↑ 2.16% |
Total Liabilities | 780.7M | ↑ 12.54% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.4B | ↑ 175.39% |
Total Liabilities | 130.4M | ↓ 83.29% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.4B | ↑ 5.03% |
Total Liabilities | 185.0M | ↑ 41.79% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 1.2B | ↓ 15.79% |
Total Liabilities | 133.7M | ↓ 27.71% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 589.7M | ↓ 51.57% |
Total Liabilities | 109.5M | ↓ 18.09% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.2B | ↓ 1.15% |
Total Liabilities | 133.7M | ↑ 5.34% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 850.5M | ↓ 30.15% |
Total Liabilities | 136.2M | ↑ 1.89% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 772.2M | ↓ 9.21% |
Total Liabilities | 128.5M | ↓ 5.68% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 635.0M | ↓ 17.76% |
Total Liabilities | 115.3M | ↓ 10.26% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 589.7M | ↓ 7.13% |
Total Liabilities | 109.5M | ↓ 5.02% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 548.4M | ↓ 7.01% |
Total Liabilities | 125.0M | ↑ 14.16% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -74.0M | - |
Investing Cash Flow | -245.9M | - |
Financing Cash Flow | 278.2M | - |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -81.9M | ↑ 10.66% |
Investing Cash Flow | 120.0M | ↓ 148.79% |
Financing Cash Flow | 46.6M | ↓ 83.23% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -112.5M | ↑ 37.33% |
Investing Cash Flow | -66.8M | ↓ 155.63% |
Financing Cash Flow | 983.1M | ↑ 2007.93% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -141.5M | ↑ 25.85% |
Investing Cash Flow | -59.6M | ↓ 10.67% |
Financing Cash Flow | 5.8M | ↓ 99.41% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -192.3M | ↑ 35.88% |
Investing Cash Flow | -11.6M | ↓ 80.5% |
Financing Cash Flow | -3.6M | ↓ 162.77% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -35.9M | ↓ 29.49% |
Investing Cash Flow | 239.7M | ↑ 91.87% |
Financing Cash Flow | 417.0K | ↓ 72.2% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -29.1M | ↓ 18.91% |
Investing Cash Flow | -397.7M | ↓ 265.93% |
Financing Cash Flow | 1.6M | ↑ 273.14% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -39.6M | ↑ 35.95% |
Investing Cash Flow | 195.4M | ↓ 149.12% |
Financing Cash Flow | -305.0K | ↓ 119.6% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -38.0M | ↓ 4.13% |
Investing Cash Flow | 195.4M | ↑ 0.0% |
Financing Cash Flow | 896.0K | ↓ 393.77% |
Sell
Neutral
Buy
American Well Corporation is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
American Well Corporation | -13.09% | -59.32% | -78.48% | -95.84% | -97.92% |
Solventum Corp | -1.37% | -11.4% | -11.4% | -11.4% | -11.4% |
Veeva Systems Inc. | 5.11% | 19.08% | 26.56% | -20.38% | 44.87% |
Ge Healthcare Technologies Inc. | -2.81% | 11.33% | 3.62% | 35.46% | 35.46% |
Healthequity Inc | -2.32% | 18.78% | 35.6% | 2.03% | 13.46% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
American Well Corporation | NA | NA | NA | -0.82 | -0.62 | -0.23 | NA | 1.38 |
Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
Veeva Systems Inc. | 65.41 | 65.41 | 1.35 | 4.76 | 0.13 | 0.05 | NA | 28.8 |
Ge Healthcare Technologies Inc. | 23.71 | 23.71 | 20.11 | 4.27 | 0.22 | 0.06 | 0.0 | 16.23 |
Healthequity Inc | 124.06 | 124.06 | 2.29 | 2.19 | 0.03 | 0.03 | NA | 23.63 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
American Well Corporation | Hold | $150.7M | -97.92% | NA | -137.32% |
Solventum Corp | NA | $10.8B | -11.4% | NA | 15.73% |
Veeva Systems Inc. | Buy | $33.9B | 44.87% | 65.41 | 22.24% |
Ge Healthcare Technologies Inc. | Buy | $37.2B | 35.46% | 23.71 | 8.05% |
Healthequity Inc | Buy | $6.9B | 13.46% | 124.06 | 5.57% |
RIMA MANAGEMENT, LLC
BlackRock Inc
Caledonia (Private) Investments Pty Ltd
Vanguard Group Inc
SATTER MANAGEMENT CO., L.P.
Morgan Stanley - Brokerage Accounts
American Well Corporation’s price-to-earnings ratio stands at None
Read Moreamwell (previously known as american well) is a leading telehealth platform in the united states and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. amwell believes that digital care delivery will transform healthcare. the company offers a single, comprehensive platform to support all telehealth needs from urgent to acute and post-acute care, behavioral health, as well as chronic care management and healthy living. with over a decade of experience, amwell powers telehealth solutions for over 240 health systems comprised of 2,000 hospitals and 55 health plan partners with over 36,000 employers, reaching over 80 million lives.
Organization | American Well Corporation |
Employees | 1104 |
CEO | Dr. Ido Schoenberg M.D. |
Industry | Technology Services |
A Spac I Acquisition Corp
$0.50
+3.31%
Keyarch Acquisition Corp
$0.50
+3.31%
Connexa Sports Technologies Inc
$0.50
+3.31%
Us Value Etf
$0.50
+3.31%
First Wave Biopharma Inc
$0.50
+3.31%
Global X Msci Next Emerging
$0.50
+3.31%
Fat Projects Acquisition Corp
$0.50
+3.31%
Ishares Intl Div Growth Etf
$0.50
+3.31%
Corsair Gaming, Inc.
$0.50
+3.31%